Natera Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Hey, everyone. Good morning. Thanks for joining us on day 3 of our healthcare conference. I'm Tejas Savant, and I cover the life science tools and diagnostics sector here at Morgan Stanley. Delighted to have Natera join us today. And representing the company, we have Steve Chapman, CEO; and Mike Brophy, CFO. Thanks for joining us, guys.
Sure.
Questions & Answers
For important disclosures before we get to the Q&A, please see the research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your sales rep. With that out of the way, Steve, let's get right to it, a lot of ground to cover this morning.
So maybe I'll start on the Prospera side of things where you have the most exciting news recently on the launch of heart transplant
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |